Hyperbaric Oxygen Treatment in Autism Spectrum Disorders
Effect of Hyperbaric Oxygen Therapy (HBOT) in Children With Autism Spectrum Disorder (ASD)
Sponsor: General Administration of Military Health, Tunisia
Listed as NCT04472780, this NA trial focuses on Child Autism and remains ongoing. Sponsored by General Administration of Military Health, Tunisia, it has been updated 7 times since 2019, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Oct 2021 — Oct 2023 [monthly]
Recruiting NA
-
Mar 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- General Administration of Military Health, Tunisia
- Military Hospital of Tunis
For direct contact, visit the study record on ClinicalTrials.gov .